Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8718 |
High Similarity |
NPD2801 |
Approved |
0.8481 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8418 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8415 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8377 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8344 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8289 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8261 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8235 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8133 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8092 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8089 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8089 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8067 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8067 |
Intermediate Similarity |
NPD943 |
Approved |
0.8047 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8037 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8036 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7988 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7974 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD1607 |
Approved |
0.795 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7914 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7892 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7849 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7674 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7665 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD3750 |
Approved |
0.759 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7578 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7529 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7459 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7439 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD37 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.74 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7349 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7325 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7314 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7312 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7294 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7247 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7216 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD919 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7133 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7126 |
Intermediate Similarity |
NPD920 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7117 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7102 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD6779 |
Approved |
0.709 |
Intermediate Similarity |
NPD6782 |
Approved |
0.709 |
Intermediate Similarity |
NPD6781 |
Approved |
0.709 |
Intermediate Similarity |
NPD6777 |
Approved |
0.709 |
Intermediate Similarity |
NPD6778 |
Approved |
0.709 |
Intermediate Similarity |
NPD6780 |
Approved |
0.709 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7086 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7068 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7032 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7006 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1201 |
Approved |
0.6988 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD2798 |
Approved |
0.6979 |
Remote Similarity |
NPD7697 |
Approved |
0.6979 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6979 |
Remote Similarity |
NPD7698 |
Approved |
0.6978 |
Remote Similarity |
NPD8313 |
Approved |
0.6978 |
Remote Similarity |
NPD8312 |
Approved |
0.6961 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6949 |
Remote Similarity |
NPD5242 |
Approved |
0.6943 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6931 |
Remote Similarity |
NPD7907 |
Approved |
0.6927 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD4749 |
Approved |
0.6899 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6886 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD7240 |
Approved |
0.6867 |
Remote Similarity |
NPD7003 |
Approved |
0.6859 |
Remote Similarity |
NPD1876 |
Approved |
0.6859 |
Remote Similarity |
NPD6696 |
Suspended |
0.6853 |
Remote Similarity |
NPD7874 |
Approved |
0.6853 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD9717 |
Approved |
0.6835 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD5406 |
Approved |
0.6829 |
Remote Similarity |
NPD5408 |
Approved |
0.6829 |
Remote Similarity |
NPD5405 |
Approved |
0.6829 |
Remote Similarity |
NPD5404 |
Approved |
0.6825 |
Remote Similarity |
NPD6534 |
Approved |
0.6825 |
Remote Similarity |
NPD6535 |
Approved |
0.6821 |
Remote Similarity |
NPD9493 |
Approved |
0.6818 |
Remote Similarity |
NPD7801 |
Approved |
0.6818 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD1203 |
Approved |
0.6813 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6813 |
Remote Similarity |
NPD3764 |
Approved |
0.6806 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6806 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6805 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.6793 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6788 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6782 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6782 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6776 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6776 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6774 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6763 |
Remote Similarity |
NPD5089 |
Approved |
0.6763 |
Remote Similarity |
NPD6386 |
Approved |
0.6763 |
Remote Similarity |
NPD6385 |
Approved |
0.6763 |
Remote Similarity |
NPD5090 |
Approved |
0.6757 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6753
|
Remote Similarity |
NPD4626 |
Approved |